Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
AMNEAL PHARMACEUTICALS, INC. (AMRX) had Weighted-Average Shares Outstanding (Diluted) of 324.81M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$3.02B |
|
$72.06M |
|
$1.91B |
|
$1.11B |
|
$2.62B |
|
$394.10M |
|
$-254.89M |
|
$139.21M |
|
$139.21M |
|
$127.93M |
|
$127.93M |
|
$127.93M |
|
$127.93M |
|
$394.10M |
|
$640.10M |
|
313.37M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
324.81M |
$0.23 |
|
$0.22 |
|
| Balance Sheet Financials | |
$1.91B |
|
$442.95M |
|
$1.77B |
|
$3.68B |
|
$881.63M |
|
$2.62B |
|
$2.87B |
|
$3.75B |
|
$-71.33M |
|
$-1.23B |
|
$-71.33M |
|
314.56M |
|
| Cash Flow Statement Financials | |
$339.99M |
|
$-112.26M |
|
$-31.53M |
|
$118.42M |
|
$312.94M |
|
$194.52M |
|
$31.95M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.17 |
|
-- |
|
-- |
|
1.03 |
|
-36.87 |
|
36.88% |
|
13.05% |
|
13.05% |
|
21.20% |
|
4.61% |
|
2.39% |
|
$243.24M |
|
-- |
|
-- |
|
-- |
|
0.82 |
|
3.14 |
|
3.37 |
|
108.29 |
|
-179.36% |
|
-10.40% |
|
3.48% |
|
5.02% |
|
$-0.23 |
|
$0.75 |
|
$1.05 |
|